Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for… EP News Bureau Jun 7, 2022 Boehringer Ingelheim holds a valid patent for Linagliptin in India until August 2023
DawaaDost announces one day’s Diabetes course of ‘Metformin 1000 mg’ at Re 1 per day EP News Bureau Nov 15, 2021 Through this programme, DawaaDost will retail Metformin 1000 mg tablets from the top 10 pharmaceutical companies in the country
Micro Labs launches anti-diabetic drug combo, Dapagliflozin plus Metformin EP News Bureau Nov 24, 2020 The drug comes in two strengths ZUCAPRIDE–M 500 priced at Rs12.80 per tablet and ZUCAPRIDE–M 1000 at Rs 14.80